Given the variability of our results in MYOC gene expression upon treatment with EVs derived from imCSSCs, combined with the current lack of knowledge regarding its involvement in glaucoma pathogenesis, it is challenging to draw any definitive conclusions. This evidence concerns the gene MYOC and glaucoma.